Barley and kefir to support gut health in active adults
Official title: Effects of a Four-Week Dietary Intervention With Barley and Kefir on Gut Microbiota, Circulating Metabolites, and Health Outcomes in Physically Active Adults: A Randomized Controlled Trial
Run by Western Norway University of Applied Sciences · NCT07864779 · Data updated 2026-11-12
This study tests whether a daily barley and kefir meal for four weeks can change gut microbiota in physically active adults and whether those changes relate to certain metabolites in blood and urine.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 55 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Western Norway University of Applied Sciences Academic / other |
| Locations | 1 site (Bergen) |
| Status | Recruiting |
| Started | September 7, 2026 |
| Main results expected | June 2031 |
| Study ends | June 2031 |
| Registry record updated | October 23, 2026 |
| Trial ID | NCT07864779 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 18–55 who engage in endurance-type activities and have high VO2max values as defined in the criteria, without milk allergy, lactose intolerance, or recent antibiotic use.
✕Probably not a fit
Individuals with dairy intolerance or milk allergy, or those recently treated with antibiotics, may not experience benefit from this barley-kefir intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial evaluates a practical four-week dietary intervention using barley and kefir to modulate gut microbiota in endurance athletes or active adults. Participants will consume a daily meal containing barley and kefir, with analysis of gut microbiota diversity and composition before and after the intervention, alongside circulating and urinary metabolite measurements. The study aims to link diet-induced microbial changes to metabolomic profiles, shedding light on how everyday foods may influence metabolism and health in active individuals. Eligibility targets adults aged 18–55 with high aerobic capacity, excluding those with conditions or allergies that affect gut health or dairy intake. The lead sponsor is Western Norway University of Applied Sciences, with the trial conducted at their Bergen campus.
Why it matters
Potential benefit: If successful, the intervention could offer a practical dietary approach to promote a healthier gut microbiota in active adults and potentially support metabolic health.
How similar studies have gone: Previous work suggests diet can influence gut microbiota, but applying barley and kefir in athletic populations is relatively novel and its effects are not yet proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 - 55 years * High aerobic capacity defined by the following minimum estimated VO₂max values: Men: * 20-29 years: ≥ 51 mL/kg/min * 30-39 years: ≥ 47 mL/kg/min * 40-49 years: ≥ 43 mL/kg/min * 50-55 years: ≥ 38 mL/kg/min Women: * 20-29 years: ≥ 44 mL/kg/min * 30-39 years: ≥ 40 mL/kg/min * 40-49 years: ≥ 36 mL/kg/min * 50-55 years: ≥ 32 mL/kg/min Exclusion Criteria: * Pregnancy * Ulcerative colitis * Crohn's disease * Coeliac disease * Milk allergy * Lactose intolerance * Use of antibiotics within the previous 6 months
Where it's running
-
Western Norway University of Applied Sciences
Bergen, Norway Recruiting
Study contacts
- Principal investigator: Iselin T Vildmyren, PhD — Western Norway University of Applied Sciences
- Study coordinator: Iselin T Vildmyren, PhD
- Email: isvi@hvl.no
- Phone: +4798699287
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Probiotics to Prevent Pneumonia in Critically Ill Kids in the PICU
We’re testing whether giving probiotics to critically ill children on a ventilator helps prevent ventilator-associated pneumonia.
-
Probiotic mix to see if it boosts fullness in adults who are overweight or have obesity
A probiotic supplement is being tested in adults aged 20-70 who are overweight or have obesity to see if it makes them feel fuller and changes gut bacteria harder after 16 weeks, compared with a placebo.
-
Probiotic Y7 cocktail to help with early Parkinson’s symptoms
A 12-week randomized trial will test whether a probiotic Y7 cocktail helps people with early Parkinson’s disease by possibly improving motor, thinking, and everyday symptoms.
-
How gut microbes affect blueberry polyphenol metabolites in healthy adults
This study tests whether differences in the gut microbiome change how healthy adults metabolize blueberry polyphenols after a single blueberry dose.
-
How common dietary fats change gut bacteria and metabolic markers
We will test whether replacing part of daily fat with butter, coconut oil, olive oil, or sunflower oil for two weeks changes gut bacteria and related blood markers in healthy adults aged 20–50.
-
Virtual approaches for period pain in young women
This study tests two online self-care options—auricular acupressure and Baduanjin qigong—against a self-care education group to see if they reduce menstrual pain and related symptoms in young women.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.